Alyeska Investment Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-76,575	Closed	-$2.72M	–	471
2023 Q4	$2.72M	Buy	76,575 +7,073	+10%	+$252K	0.02%	333
2023 Q3	$2.07M	Buy	+69,502	New	+$2.07M	0.01%	373